RT Journal Article
SR Electronic
A1 Nierengarten, Mary Beth
T1 No Increased Coronary or Mortality Risk Associated with Changes in DAPT
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 42
SP 9
OP 10
DO 10.1177/155989771442003
UL http://mdc.sagepub.com/content/14/42/9.abstract
AB For patients discharged after acute coronary syndrome (ACS), changing from dual-antiplatelet therapy (DAPT) to less potent antiplatelet therapy is not associated with increased coronary or mortality risk despite a short-term excess of cardiovascular (CV) events. This article presents the results of the Long-term Follow-up of Anti-thrombotic Management Patterns in Acute Coronary Syndrome Patients [EPICOR; NCT01171404], a real-world-practice cohort study conducted to describe current international patterns of DAPT use following ACS and the clinical outcomes associated with changes in DAPT.